News
Dipyridamole bound to the SARS-CoV-2 protease Mpro after identified via the virtual screening and bioassay validation, and thus suppressed viral replication in vitro. As a result, dipyridamole ...
By virtual screening of a U.S. FDA approved drug library, the authors identified an anticoagulation agent dipyridamole (DIP) in silico, which suppressed SARS-CoV-2 replication in vitro.
Cite this article PHILP, R., LEMIEUX, V. Comparison of Some Effects of Dipyridamole and Adenosine on Thrombus Formation, Platelet Adhesiveness and Blood Pressure in Rabbits and Rats. Nature 218 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback